CSL-112, a r-HDL particle that promotes the formation of small and lipid-poor APOA1 particles,18,19 is being tested in a large, randomized study to determine if it reduces the risk of CVD events in patients after myocardial infarction. This evidence concerns the gene APOA1 and myocardial infarction.